Insulin doses requirements in patients with type 1 diabetes using glargine U300 or degludec in routine clinical practice

por Carral San Laureano, Florentino, Tomé Fernández-Ladreda, Mariana, Jiménez Millán, Ana Isabel, García Calzado, Concepción, Ayala Ortega, María del Carmen
Publicado 2021

Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain

por Garcia de Lucas, Maria Dolores, Miramontes-González, Jose Pablo, Avilés-Bueno, Beatriz, Jiménez-Millán, Ana Isabel, Rivas-Ruiz, Francisco, Pérez-Belmonte, Luis M.
Publicado 2022